Gwendolyn Dunevant Coffey, NP

Gwendolyn Coffey practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Gwendolyn Coffey's NPI, 1659423705, was assigned on January 17, 2007. Gwendolyn Coffey holds California license 10083.

Gwendolyn Coffey's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Gwendolyn Coffey's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Gwendolyn Coffey is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Gwendolyn Coffey to 1 more hospital, named with a free account. Gwendolyn Coffey's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Gwendolyn Coffey practices, 3 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Gwendolyn Coffey's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Gwendolyn Coffey is licensed in California.

Dmand AI lists epilepsy and itchy rashes among the conditions Gwendolyn Coffey treats.

CMS data shows 159 Medicare services from Gwendolyn Coffey across 3 procedure codes in 2024, for 56 Medicare patients. Medicare paid $16,338 for them.

CMS counts 56 Medicare patients who saw Gwendolyn Coffey in 2024. The largest group is 65 to 74, with 25 patients. 61% of them have high cholesterol, and 59% have high blood pressure. 32% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Gwendolyn Coffey's median patient age at 54, with 48% women.

In 2024, Gwendolyn Coffey wrote 222 Medicare Part D claims for 51 patients. 71% of them were for generic drugs. CMS names the drug for 138 of them, across 8 drugs with 11 or more claims each, at $663,976 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Gwendolyn Coffey for performance year 2024, reported as part of a group. Gwendolyn Coffey accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Gwendolyn Coffey as offering telehealth.

CMS Open Payments shows 1 general payment to Gwendolyn Coffey from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $21.